SCHEMBL7248643

SCHEMBL7248643

Cn1cc2c(n1)-c1c(Cc3ccccc3)sc(C(N)=O)c1CC2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD4 P21917 3/20 0.44
CCNC P24863 9/20 0.39
CDK8 P49336 9/20 0.39
CDK19 Q9BWU1 9/20 0.39
CCNA2 P20248 3/20 0.38
CDK2 P24941 3/20 0.38
CCNA1 P78396 3/20 0.38
PLK1 P53350 1/20 0.38
AURKA O14965 1/20 0.38
USP2 O75604 1/20 0.37
ALDH1A1 P00352 1/20 0.37
MAPT P10636 1/20 0.37
HPGD P15428 1/20 0.37
ALOX15 P16050 1/20 0.37
RECQL P46063 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
HSD17B10 Q99714 1/20 0.37
DRD2 P14416 1/20 0.37
BRD4 O60885 1/20 0.36
IKBKB O14920 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7249355 0.92 DRD4 (0.45) DRD4CCNCCDK8CDK19CCNA2
SCHEMBL7039651 0.86 ALDH1A1 (0.43) DRD4CCNA2CDK2CCNA1ALDH1A1
SCHEMBL7241971 0.81 DRD4 (0.45) DRD4CCNCCDK8CDK19ALDH1A1
SCHEMBL7242734 0.79 DRD4 (0.44) DRD4CCNCCDK8CDK19ALDH1A1
SCHEMBL7039119 0.79 CCNC (0.61) DRD4CCNCCDK8CDK19CCNA2
SCHEMBL7246693 0.79 DRD4 (0.67) DRD4CCNCCDK8CDK19DRD2
SCHEMBL7249485 0.78 CCNC (0.50) CCNCCDK8CDK19PLK1CDK9
SCHEMBL7247549 0.77 MAPT (0.46) DRD4CCNCCDK8CDK19MAPT
SCHEMBL7250017 0.77 DRD4 (0.36) DRD4CCNCCDK8CDK19CCNA2
SCHEMBL7243276 0.76 CCNC (0.61) DRD4CCNCCDK8CDK19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030158245-A1 Fused heterocyclic derivatives, their production and use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2003-08-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030158245-A1 Fused heterocyclic derivatives, their production and use TST, STS, AHR DRD4 567/4885CCNC 2012/4885CDK8 3614/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.